US Patent No: 6,150,352

Number of patents in Portfolio can not be more than 2000

Antagonists of gonadotropin releasing hormone

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related conditions in both men and women.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
MERCK & CO., INC.RAHWAY, NJ74

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allen, Eric E Somerset, NJ 19 255
Devita, Robert J Westfield, NJ 43 313
Goulet, Mark Westfield, NJ 32 637
Jiang, Jinlong Wodbridge, NJ 27 100
Toupence, Richard B Scotch Plains, NJ 17 319
Ujjainwalla, Feroze Edison, NJ 42 168
Walsh, Thomas F Watchung, NJ 73 866
Wyvratt, Jr Matthew J Mountainside, NJ 25 320
Young, Jonathan R Dayton, NJ 43 147

Cited Art Landscape

Patent Info (Count) # Cites Year
 
MERCK SHARP & DOHME LTD. (3)
* 5,252,584 Hydroxyquinolone derivatives 18 1991
* 5,348,962 Hydroxyquinolone derivatives compounds which have pharmaceutical utility 11 1993
* 5,614,532 Quinolone derivatives 15 1994
 
SCHERING CORPORATION (2)
* 5,175,151 Antiviral compounds and antihypertensive compounds 42 1992
* 5,412,104 Ester and alkoxy substituted benzopyrans 32 1993
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PFIZER PRODUCTS INC. (1)
6,756,385 Imidazole derivatives 3 2001
 
NOVO NORDISK A/S (12)
8,119,159 Solid oral dosage form containing an enhancer 21 2006
* 2007/0196,464 Solid oral dosage form containing an enhancer 20 2006
8,323,689 Solid oral dosage form containing an enhancer 13 2008
8,999,383 Compositions of GnRH related compounds and processes of preparation 1 2009
8,883,201 Solid oral dosage form containing an enhancer 7 2009
8,053,429 Solid oral dosage form containing an enhancer 24 2009
8,883,203 Solid oral dosage form containing an enhancer 7 2010
8,323,690 Solid oral dosage form containing an enhancer 13 2010
* 2010/0209,499 Solid Oral Dosage Form Containing an Enhancer 4 2010
9,089,484 Pharmaceutical compositions of selective factor Xa inhibitors for oral administration 0 2011
8,802,114 Pharmaceutical compositions of iron for oral administration 0 2012
8,828,431 Solid oral dosage form containing an enhancer 8 2012
 
INFINITY PHARMACEUTICALS, INC. (2)
8,785,470 Heterocyclic compounds and uses thereof 3 2012
9,181,221 Chemical compounds, compositions and methods for kinase modulation 0 2013
 
MERRION RESEARCH III LIMITED (1)
* 2007/0148,228 Solid oral dosage form containing an enhancer 26 2006
 
PFIZER INC. (2)
* 2006/0149,066 Imidazole derivatives 0 2006
* 2008/0280,879 SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS 0 2008
* Cited By Examiner